Tapewire

Nasdaq · USD

AKBA

Akebia Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6105
SEC CIK
0001517022
Parsed reports
275

Last 12 months

Inside the activity.

1 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 2026015
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 16, 2023 Filed May 18, 2023 22:20 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 63,567 $1.07 $67,889.56
Disclosure

SEC source: 0001562180-23-004254 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 530,487

F1 · shares: This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on May 12, 2022.

Read SEC document
May 16, 2023 Filed May 18, 2023 22:19 UTC
Spellman David ASVP, CFO and Treasurer
SaleCommon Stock 63,567 $1.07 $67,889.56
Disclosure

SEC source: 0001562180-23-004253 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 446,483

F1 · shares: This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on June 8, 2022.

Read SEC document
May 12, 2023 Filed May 16, 2023 16:09 UTC
Dahan MichelSVP, Chief Operating Officer
GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004168 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 469,515

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
May 12, 2023 Filed May 16, 2023 20:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004169 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387,530

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 08:01 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 1,878 $0.88 $1,647.95
Disclosure

SEC source: 0001562180-23-002198 · primarydocument.xml · nonDerivative · entry 3

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,515

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 08:01 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 10,476 $0.88 $9,192.69
Disclosure

SEC source: 0001562180-23-002198 · primarydocument.xml · nonDerivative · entry 2

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,393

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 08:01 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 8,058 $0.88 $7,070.90
Disclosure

SEC source: 0001562180-23-002198 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,869

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 6,370 $0.88 $5,589.68
Disclosure

SEC source: 0001562180-23-002201 · primarydocument.xml · nonDerivative · entry 3

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,568,872

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 47,239 $0.88 $41,452.22
Disclosure

SEC source: 0001562180-23-002201 · primarydocument.xml · nonDerivative · entry 2

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,575,242

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 38,259 $0.88 $33,572.27
Disclosure

SEC source: 0001562180-23-002201 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,622,481

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 1,088 $0.88 $954.72
Disclosure

SEC source: 0001562180-23-002200 · primarydocument.xml · nonDerivative · entry 3

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,530

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 6,613 $0.88 $5,802.91
Disclosure

SEC source: 0001562180-23-002200 · primarydocument.xml · nonDerivative · entry 2

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,618

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 5,333 $0.88 $4,679.71
Disclosure

SEC source: 0001562180-23-002200 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,231

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 1,110 $0.88 $974.03
Disclosure

SEC source: 0001562180-23-002199 · primarydocument.xml · nonDerivative · entry 3

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594,054

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 6,400 $0.88 $5,616.00
Disclosure

SEC source: 0001562180-23-002199 · primarydocument.xml · nonDerivative · entry 2

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595,164

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:01 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 6,613 $0.88 $5,802.91
Disclosure

SEC source: 0001562180-23-002199 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 601,564

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:00 UTC
Spellman David ASVP, CFO and Treasurer
SaleCommon Stock 810 $0.88 $710.78
Disclosure

SEC source: 0001562180-23-002197 · primarydocument.xml · nonDerivative · entry 2

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 510,050

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 13:00 UTC
Spellman David ASVP, CFO and Treasurer
SaleCommon Stock 6,400 $0.88 $5,616.00
Disclosure

SEC source: 0001562180-23-002197 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 510,860

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 16:06 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 10,090 $0.81 $8,205.19
Disclosure

SEC source: 0001562180-23-002039 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,927

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

F2 · balance_after: Includes 1,500 shares of the Issuers common stock purchased on June 30, 2022, and 1,500 shares of the Issuers common stock purchased on December 30, 2022, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:07 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 38,632 $0.81 $31,415.54
Disclosure

SEC source: 0001562180-23-002041 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,660,740

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:06 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 7,539 $0.81 $6,130.71
Disclosure

SEC source: 0001562180-23-002040 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 608,177

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:05 UTC
Spellman David ASVP, CFO and Treasurer
SaleCommon Stock 7,539 $0.81 $6,130.71
Disclosure

SEC source: 0001562180-23-002038 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 517,260

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:05 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 6,677 $0.81 $5,429.74
Disclosure

SEC source: 0001562180-23-002037 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,564

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

F2 · balance_after: Includes 1,500 shares of the Issuers common stock purchased on June 30, 2022, and 1,500 shares of the Issuers common stock purchased on December 30, 2022, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:15 UTC
Butler John P.Director · CEO and President
GrantStock Option (Right to buy) · Derivative 875,000 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001562180-23-000832 · primarydocument.xml · derivative · entry 7

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875,000

Underlying: Common Stock · 875,000 shares

Expires 2033-01-31

F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:15 UTC
Butler John P.Director · CEO and President
GrantStock Appreciation Right · Derivative 635,313 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001562180-23-000832 · primarydocument.xml · derivative · entry 6

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 635,313

Underlying: Common Stock · 635,313 shares

Expires 2033-01-31

F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The SARs will vest over four years: 25% of the SARs will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:15 UTC
Butler John P.Director · CEO and President
GrantCommon Stock 293,125 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000832 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,699,372

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2022 and 1,500 shares of the Issuer's common stock purchased on December 30, 2022, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:14 UTC
Spellman David ASVP, CFO and Treasurer
GrantStock Option (Right to buy) · Derivative 294,300 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001562180-23-000831 · primarydocument.xml · derivative · entry 2

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,300

Underlying: Common Stock · 294,300 shares

Expires 2033-01-31

F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:14 UTC
Spellman David ASVP, CFO and Treasurer
GrantCommon Stock 196,200 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000831 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 524,799

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:14 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantStock Option (Right to buy) · Derivative 294,300 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001562180-23-000830 · primarydocument.xml · derivative · entry 2

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,300

Underlying: Common Stock · 294,300 shares

Expires 2033-01-31

F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:14 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantCommon Stock 196,200 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000830 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 615,716

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on December 30, 2022 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
August 31, 2022 Filed Sep 1, 2022 20:15 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 1,147 $0.36 $415.79
Disclosure

SEC source: 0001562180-22-006402 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 418,016

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2022, under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 21:00 UTC
Wolf MylesDirector
GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-004978 · primarydocument.xml · derivative · entry 2

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 21:00 UTC
Wolf MylesDirector
GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004978 · primarydocument.xml · nonDerivative · entry 1

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,681

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:56 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-004973 · primarydocument.xml · derivative · entry 2

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:56 UTC
ADAMS ADRIANDirector
GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004973 · primarydocument.xml · nonDerivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,800

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:58 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-004976 · primarydocument.xml · derivative · entry 2

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:58 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004976 · primarydocument.xml · nonDerivative · entry 1

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,029

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 21:01 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-004980 · primarydocument.xml · derivative · entry 2

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 21:01 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004980 · primarydocument.xml · nonDerivative · entry 1

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,700

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 16:58 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-004975 · primarydocument.xml · derivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 16:58 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004975 · primarydocument.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,130

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:59 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-004977 · primarydocument.xml · derivative · entry 2

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:59 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004977 · primarydocument.xml · nonDerivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,233

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:57 UTC
FRIESON RONDirector
GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-004974 · primarydocument.xml · derivative · entry 2

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:57 UTC
FRIESON RONDirector
GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004974 · primarydocument.xml · nonDerivative · entry 1

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,700

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 12:11 UTC
Spellman David ASVP, CFO and Treasurer
GrantStock Option (Right to buy) · Derivative 200,000 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-22-005001 · primarydocument.xml · derivative · entry 2

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-06-08

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock ("the Stock Option") was granted by the Issuer pursuant to the 2014 Plan. The Stock Option will vest and become exercisable in full (100%) on May 12, 2023, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 12:11 UTC
Spellman David ASVP, CFO and Treasurer
GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-005001 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,599

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"). The RSUs will vest in full (100%) on May 12, 2023, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 03, 2022 Filed Jun 7, 2022 16:03 UTC SaleCommon Stock 4,567 $0.36 $1,653.25
Disclosure

SEC source: 0001562180-22-004870 · primarydocument.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,430

F1 · kind: This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 2, 2021.

Read SEC document
May 12, 2022 Filed May 16, 2022 20:08 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantStock Option (Right to buy) · Derivative 200,000 $0.00 Strike: $0.41 $0.00
Disclosure

SEC source: 0001562180-22-004031 · primarydocument.xml · derivative · entry 2

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-05-12

F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.

Read SEC document
May 12, 2022 Filed May 16, 2022 20:08 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004031 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,663

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.